
Protean FusionPlus
Gene fusion detection for identifying specific cancer-driving mutations like ALK, ROS1, NTRK, and RET fusions.
Get started with Protean FusionPlus
Share your records
We package your records and pre-fill the Protean FusionPlus intake — no retyping.
Start sharing →Check your coverage
See if your insurance covers this and estimate out-of-pocket cost.
Check coverage →Visit Protean
Go directly to the provider's website to learn more or enroll.
Open website →How to get started
Upload your records
Pathology, genomics, imaging — whatever you have. We extract the clinical details automatically so nothing gets retyped. Upload records →
Share with Protean FusionPlus
We package your records into a secure, HIPAA-compliant bundle and pre-fill the intake. You review and sign — that's it. Share records →
Protean FusionPlus reaches out
Their team confirms next steps directly with you — testing, scheduling, consultation, or enrollment.
About this service
Gene fusion detection for identifying specific cancer-driving mutations like ALK, ROS1, NTRK, and RET fusions.
Gene Fusion Detection
Coverage, insurance & cost
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Protean FusionPlus handles billing.
Accepted
Available
Required
Ask about this service
Answers grounded in Protean's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Who this is for
Cancer types served
Common questions in this category
Based on what other patients have asked.
Does the specific variant of the CHEk2 mutation make a difference? I have the Ashkenazi Founder variant.
Is the CHEK2 mutation related to prostate cancer
What should I know as a newly diagnosed CRC patient
Colorectal CancerWhat should I ask my oncologist after a new diagnosis
Should I get BRCA genetic testing
What should I ask my oncologist about stage 2 breast cancer
Also consider
Other providers in similar categories.
Tempus
5 offeringsTempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Foundation Medicine
4 offeringsFoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Invitae
2 offeringsInvitae offers genetic testing for hereditary cancer syndromes including BRCA1/2, Lynch syndrome, and other inherited cancer risks.
Guardant Health
Guardant360 is a comprehensive liquid biopsy test that analyzes ctDNA to identify genomic alterations and guide treatment decisions.
Get personalized guidance for your case
This page is general information. Upload your records for analysis specific to YOUR diagnosis.